Journal article

Ranibizumab therapy for choroidal neovascularization secondary to non-age-related macular degeneration causes

Robyn Troutbeck, Roland Bunting, Anton van Heerdon, Melinda Cain, Robyn Guymer

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | WILEY-BLACKWELL | Published : 2012

Abstract

BACKGROUND: To investigate the efficacy of ranibizumab therapy for choroidal neovascular (CNV) membranes secondary to conditions other than macular degeneration. DESIGN: Prospective case series conducted at the Royal Victorian Eye and Ear Hospital. PARTICIPANTS: Twelve-month follow-up data for 41 patients with CNV recruited from the outpatient clinic from May 2008 to April 2010 is presented. Fifteen patients had myopia, seven had multifocal choroiditis, and eight had other primary causes. METHODS: All patients had visual acuity, fluorescein angiogram and optical coherence tomography performed at the initial visit (baseline). Ranibizumab was injected with a standard sterile technique. Patient..

View full abstract